EP-1341: Pelvic SABR with HDR boost in intermediate and high risk prostate cancer (spare): early results. (May 2017) - Musunuru, H.B.; Deabreu, A.; Davidson, M.; Ravi, A.; Hlou, J.; Ho, L.; Cheung, P.; Vesprini, D.; Liu, S.; Chu, W.; Chung, H.; Zhang, L.; et al.